Literature DB >> 1728614

Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues.

Y Ura1, A S Dion, C J Williams, B D Olsen, E S Redfield, M Ishida, M Herlyn, P P Major.   

Abstract

Membranes were prepared from 31 breast-cancer specimens and adjacent mammary tissues, dot-blotted to nitrocellulose paper, and reacted with monoclonal antibodies (MAbs) (A, B, Lewis a, Lewis b, sialylated Lewis a, Lewis x, and Lewis y) and lectins (Ulex europaeus, peanut agglutinin) having various blood-group specificities. The expression of epithelial membrane antigen was assayed with MAb MA5. The ratio of breast-cancer to normal mammary membrane preparations (C/N ratios) of these reagents was measured by densitometric scanning. We observed a decrease in the levels of A, B, Lewis a, Lewis b, sialylated Lewis a, and Lewis y antigens and an increase of Lewis x, T, and MA5-reactive determinants in breast cancers. The incidence of incompatible A, as well as A and B, antigens was demonstrated for 2 patients of blood group B and O respectively. When the receptor content was plotted against the C/N ratio of these various reagents, a significant inverse relationship between the C/N ratio of Lewis x antigen and estrogen (ER) and progesterone receptor (PR) content was observed in breast cancers. The mean C/N ratio of Lewis x antigen was significantly higher in the ER-negative/PR-negative (ER-/PR-; 2.33 +/- 1.17), as compared with the ER-positive/PR-positive (ER+/PR+; 0.97 +/- 0.80). According to these observations, Lewis x antigen expression may be influenced by hormonal stimuli such as estrogen and progesterone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728614     DOI: 10.1002/ijc.2910500113

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.

Authors:  Gary F Clark; Paola Grassi; Poh-Choo Pang; Maria Panico; David Lafrenz; Erma Z Drobnis; Michael R Baldwin; Howard R Morris; Stuart M Haslam; Sophia Schedin-Weiss; Wei Sun; Anne Dell
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

2.  Localization of binding sites of Ulex europaeus I, Helix pomatia and Griffonia simplicifolia I-B4 lectins and analysis of their backbone structures by several glycosidases and poly-N-acetyllactosamine-specific lectins in human breast carcinomas.

Authors:  N Ito; S Imai; S Haga; C Nagaike; Y Morimura; K Hatake
Journal:  Histochem Cell Biol       Date:  1996-09       Impact factor: 4.304

Review 3.  O-linked glycosylation in the mammary gland: changes that occur during malignancy.

Authors:  J M Burchell; A Mungul; J Taylor-Papadimitriou
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

Review 4.  Tumour-associated carbohydrate antigens in breast cancer.

Authors:  Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy
Journal:  Breast Cancer Res       Date:  2010-06-08       Impact factor: 6.466

5.  A, B, H, and Lewis-a and Lewis-b blood group antigens in human breast cancer: correlation with steroid hormone receptor and disease status.

Authors:  H A Idikio; V Manickavel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.

Authors:  Tatiana Pochechueva; Francis Jacob; Andre Fedier; Viola Heinzelmann-Schwarz
Journal:  Metabolites       Date:  2012-11-14

Review 7.  [Role of Fucosylation in Cancer].

Authors:  Kun Zhang; Hong Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-11-20

8.  Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).

Authors:  Marina Isla Larrain; Sandra Demichelis; Marina Crespo; Ezequiel Lacunza; Alberto Barbera; Aldo Cretón; Francisco Terrier; Amada Segal-Eiras; María Virginia Croce
Journal:  J Exp Clin Cancer Res       Date:  2009-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.